PAPER
A New Synthesis of Dihydrexidine
719
2-(3,4-Dihydro-6,7-dimethoxy-2-nitronaphthalen-1-yl)benzoic
Acid (13)
Concentration and cooling of the mother liquor yielded a second
crop to afford the lactam 15; total yield: 1.10 g (91%); mp 258–260
°C.
1H NMR (300 MHz, CDCl3): d = 8.08 (dd, 1 H, ArH), 7.67 (d, 1 H,
ArH), 7.50 (td, 1 H, ArH), 7.40 (t, 1 H, ArH), 6.98 (s, 1 H, ArH),
6.72 (br s, 1 H, CONH), 6.68 (s, 1 H, ArH), 4.24 (d, J = 12 Hz, 1 H,
ArCHAr), 3.88 (2s, 6 H, 2 OCH3), 3.66 (dt, Jtrans = 12.3 Hz, Jvic = 3
Hz, 1 H, CHN), 2.90–2.75 (m, 2 H, ArCH2), 2.11 (m, 1 H, CH2),
1.92 (dq, Jtrans = 12.3 Hz, Jvic = 5.1 Hz, 1 H, CH2).
Ester 12 (4.61 g, 11.9 mmol) was dissolved in a warm mixture of
THF (100 mL) and MeOH (100 mL). DBU (4.45 mL, 29.7 mmol)
was added and the mixture was stirred overnight. The mixture was
then diluted with H2O (200 mL), and extracted with Et2O (2 × 50
mL). The aqueous soln was acidified to pH 6 and extracted with
EtOAc–CH2Cl2 (20:1) (to aid phase separation). The combined or-
ganic extracts were washed with 2 M HCl (1 ×), then with brine (1
×). The soln was dried (Na2SO4) and filtered and the solvents were
removed to leave a bright yellow solid that was dried under vacuum;
crude yield: 4.12 g (97%). An analytical sample was prepared by re-
crystallization (EtOAc–hexanes); mp 148–154 °C.
MS (ESI): m/z (%) = 310 (100) [M + H]+.
Anal. Calcd for C19H19NO3: C, 73.77; H, 6.19; N, 4.53. Found: C,
73.39; H, 6.21; N, 4.58.
1H NMR (300 MHz, CDCl3): d = 8.20 (dd, 1 H, ArH), 7.64 (td, 1 H,
ArH), 7.51 (td, 1 H, ArH), 7.16 (dd, 1 H, ArH), 6.77 (s, 1 H, ArH),
5.99 (s, 1 H, ArH), 3.91 (s, 3 H, OCH3), 3.49 (s, 3 H, OCH3), 3.07–
2.94 (m, 4 H, 2CH2).
trans-5,6,6a,7,8,12b-Hexahydro-10,11-dimethoxyben-
zo[a]phenanthridine Hydrochloride (16)16
To a suspension of lactam 15 (460 mg, 1.49 mmol) in anhyd THF
(30 mL) was added 1 M BH3 in THF (5 mL). This mixture was heat-
ed at reflux and stirred for 18 h. The clear soln was then cooled,
quenched with H2O, and its volume reduced to one-third under re-
duced pressure. H2O was added, and the mixture was extracted with
EtOAc (4 × 10 mL). The combined organic extracts were washed
with H2O, dried (MgSO4), and filtered and the solvents were re-
moved under reduced pressure. The residue was dissolved in 2 M
HCl in EtOH (10 mL). This soln was stirred at 40 °C for 1 h and then
concentrated to dryness under vacuum. The residue was crystallized
(MeCN) to afford the HCl salt in two batches; yield: 350 mg (71%);
mp 243 °C. The NMR spectrum and other properties were identical
to those reported previously.16
MS (ESI): m/z (%) = 378 (100) [M + Na]+.
Anal. Calcd for C19H17NO6: C, 64.22; H, 4.82; N, 3.94. Found: C,
64.54; H, 4.78; N, 3.63.
trans-2-(1,2,3,4-Tetrahydro-6,7-dimethoxy-2-nitronaphthalen-
1-yl)benzoic Acid (14)
Nitroalkene 13 (2.00 g, 5.63 mmol) was dissolved in i-PrOH (250
mL), NaBH4 (638 mg, 16.9 mmol) was added, and the mixture was
stirred and heated at reflux for 12 h. Additional NaBH4 (275 mg,
24.1 mmol total) was then added and the mixture was stirred for an
additional 6 h at reflux, at which time the yellow color had been
completely discharged. The suspension was concentrated to one-
third of its original volume under reduced pressure and a concen-
trated soln of urea in 1% AcOH was then added until pH 6. The mix-
ture was then extracted with CH2Cl2 (3 × 50 mL); the combined
organic extracts were washed with H2O (2 ×), dried (MgSO4), and
filtered and the solvents were removed under reduced pressure. The
residual light green solid was triturated under warm EtOAc, cooled,
and filtered to yield 14; yield: 1.44 g (71%); mp 185–190 °C.
trans-5,6,6a,7,8,12b-Hexahydro-10,11-dihydroxyben-
zo[a]phenanthridine Hydrochloride (1·HCl)16
Compound 1 was prepared following the procedure by Knoerzer et
al.16 and had identical properties to those reported therein.
Acknowledgment
1H NMR (300 MHz, DMSO-d6): d = 7.85 (d, 1 H, ArH), 7.47 (t, 1
H, ArH), 7.37 (t, 1 H, ArH), 6.99 (d, 1 H, ArH), 6.75 (s, 1 H, ArH),
6.24 (s, 1 H, ArH), 5.56 (d, J = 5.7 Hz, 1 H, ArCHAr), 5.21 (m, 1
H, CHNO2), 3.74 (s, 3 H, OCH3), 3.46 (s, 3 H, OCH3), 2.97 (m, 1
H, CH2), 2.73 (m, 1 H, CH2), 2.29 (m, 2 H, ArCH2).
This work was supported by NIH Grant MH42705. The work was
conducted in a facility constructed with support from Research Fa-
cilities Improvement Program Grant No. C06-14499 from the Na-
tional Center for Research Resources of the National Institutes of
Health. The authors also acknowledge Ms. Lisa Bonner for conduc-
ting NMR spectroscopy studies of many of the compounds repor-
ted.
MS (ESI): m/z (%) = 380 (100) [M + Na]+.
Anal. Calcd for C19H19NO6: C, 63.86; H, 5.36; N, 3.92. Found: C,
63.59; H, 5.52; N, 3.78.
References
trans-6a,7,8,12b-Tetrahydro-10,11-dimethoxybenzo[a]phenan-
thridin-5(6H)-one (15)
(1) Brewster, W. K.; Nichols, D. E.; Riggs, R. M.; Mottola, D.
M.; Lovenberg, T. W.; Lewis, M. H.; Mailman, R. B. J. Med.
Chem. 1990, 33, 1756.
Acid 14 (1.40 g, 3.92 mmol) was dissolved in warm CH2Cl2 (50
mL) and the soln was allowed to cool to r.t. MeOH (0.18 mL, 4.3
mmol), DCC 889 mg (4.31 mmol), and DMAP (48 mg, 0.39 mmol)
were then added. A precipitate began to form almost immediately,
and the mixture was stirred for 3 h. The solvents were then removed
under reduced pressure, the residue was dissolved in Et2O (30 mL),
and the suspension was filtered to remove DCU. This soln was con-
centrated to dryness to afford the crude nitro ester, which was dis-
solved in AcOH (25 mL), Zn powder (2.7 g) was added, and the
mixture was stirred for 3 h. This suspension was filtered, the zinc
and zinc salts washed on the filter with THF, and the filtrate concen-
trated under reduced pressure. The residue was made strongly basic
with 2 M NaOH (30 mL) and this mixture was extracted with
CH2Cl2 (3 × 20 mL) The combined organic extracts were washed
with H2O, dried (MgSO4), and filtered and the solvents were re-
moved under reduced pressure. The residue was dissolved in MeOH
(20 mL) and heated at reflux for 18 h, producing a white precipitate.
The flask was then cooled and the white solid collected by filtration.
(2) Huang, X.; Lawler, C. P.; Lewis, M. M.; Nichols, D. E.;
Mailman, R. B. Int. Rev. Neurobiol. 2001, 48, 65.
(3) (a) George, M. S.; Molnar, C. E.; Grenesko, E. L.; Anderson,
B.; Mu, Q.; Johnson, K.; Nahas, Z.; Knable, M.; Fernandes,
P.; Juncos, J.; Huang, X.; Nichols, D. E.; Mailman, R. B.
Schizophr. Res. 2007, 93, 42. (b) Goldman-Rakic, P. S.;
Castner, S. A.; Svensson, T. H.; Siever, L. J.; Williams, G.
V. Psychopharmacology (Berl.) 2004, 3. (c) Mu, Q.;
Johnson, K.; Morgan, P. S.; Grenesko, E. L.; Molnar, C. E.;
Anderson, B.; Nahas, Z.; Kozel, F. A.; Kose, S.; Knable, M.;
Fernandes, P.; Nichols, D. E.; Mailman, R. B.; George, M.
S. Schizophr. Res. 2007, 94, 332. (d) Nichols, D. E.; Lewis,
M. M. Med. Chem. Res. 2004, 13, 105.
(4) Ehrlich, P. P.; Michaelides, M. R.; McLaughlin, M. M.;
Hsaio, C. US 5659037, 1997.
(5) Negash, K.; Nichols, D. E. Tetrahedron Lett. 1996, 37, 6971.
Synthesis 2009, No. 5, 715–720 © Thieme Stuttgart · New York